Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics jumps most in 3 yrs on upbeat cancer drug trial results

** Shares of Amplia Therapeutics  ATX.AX  rise as much as
46.8% to A$0.091,  posting their biggest intraday percentage
gain since June 2, 2021
    ** Drug developer posts positive results from the clinical
trial of its pancreatic cancer drug narmafotinib
    ** Says results show at least a 30% decrease in the overall
size of tumour, and no new tumour lesions over two months in
three patients 
    ** About 1.3 mln shares change hands, compared with the
30-day average volume of around 300,000
    ** Stock up 5.5% YTD, including session's moves



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news